Clinical Indications of 11C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse

Several studies investigated the potential role of imaging modalities in prostate cancer patients in case of biochemical recurrence. However, the role of molecular imaging has not been well established yet. Considering the results of the literature and of our own experience, we tried to summarize the potential applications of 11C-choline PET/CT in prostate cancer patients in case of biochemical relapse for the detection of lymph node and distant recurrence.

• Publication year

  2012

• Venue

  Theranostics

• Publication date

  2012-03-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.7150/thno.4007PMID 22448197PMCID 3311232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer.

  2011cited by this paper
• Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography.

  2011cited by this paper
• [11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy

  2011cited by this paper
• Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy

  2010cited by this paper
• [11C]choline-PET-guided Helical Tomotherapy and Estramustine in a Patient with Pelvic-Recurrent Prostate Cancer: Local Control and Toxicity Profile after 24 Months

  2010cited by this paper
• PSA doubling time for prediction of [11C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy

  2010cited by this paper
• Predictive factors of [11C]choline PET/CT in patients with biochemical failure after radical prostatectomy

  2010cited by this paper
• Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?

  2010cited by this paper
• DETECTION OF LYMPH-NODE METASTASES WITH INTEGRATED [11C]CHOLINE PET/CT IN PATIENTS WITH PSA FAILURE AFTER RADICAL RETROPUBIC PROSTATECTOMY: VALIDATION BY OPEN PELVIC-RETROPERITONEAL LYMPHADENECTOMY

  2009cited by this paper
• Influence of Trigger PSA and PSA Kinetics on 11C-Choline PET/CT Detection Rate in Patients with Biochemical Relapse After Radical Prostatectomy

  2009cited by this paper
• A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy.

  2008cited by this paper
• Imaging prostate cancer: a multidisciplinary perspective.

  2007cited by this paper
• The detection rate of [11C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer

  2007cited by this paper
• Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.

  2007cited by this paper
• Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated?

  2004cited by this paper
• Predictors of metastatic disease in men with biochemical failure following radical prostatectomy.

  2004cited by this paper
• ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer.

  2003cited by this paper
• Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

  2003influential reference
• ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer.

  2003cited by this paper
• Inaugural Article: Positron emission tomography provides molecular imaging of biological processes

  2000cited by this paper
• Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy.

  1998cited by this paper
• PET imaging of prostate cancer using carbon-11-choline.

  1998cited by this paper

• Imaging at the nexus: how state of the art imaging techniques can enhance our understanding of cancer and fibrosis

  2024cites this paper
• Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis

  2022cites this paper
• Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade

  2022cites this paper
• Insight into the Development of PET Radiopharmaceuticals for Oncology

  2020cites this paper
• Are all prostate cancer patients "fit" for salvage radiotherapy?

  2020cites this paper
• Imaging of Prostate Cancer Using 64Cu-Labeled Prostate-Specific Membrane Antigen Ligand.

  2017cites this paper
• Role of PET/CT in Radiotherapy Treatment Planning

  2017cites this paper
• Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT.

  2017cites this paper
• Nuclear Medicine (Bone Scan, Choline and PSMA PET/CT)

  2017cites this paper
• 18F-Fluorocholine PET/CT Complementing the Role of Dynamic Contrast-Enhanced MRI for Providing Comprehensive Diagnostic Workup in Prostate Cancer Patients With Suspected Relapse Following Radical Prostatectomy

  2017cites this paper
• Diagnosis of Hepatocellular Carcinoma Using C11 Choline PET/CT: Comparison with F18 FDG, ContrastEnhanced MRI and MDCT.

  2016cites this paper
• Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate Cancer.

  2015cites this paper
• Prostate cancer imaging: positron-emission tomography perspectives

  2015cites this paper
• Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients

  2015cites this paper
• Lymphatic Imaging: Focus on Imaging Probes

  2015cites this paper
• Exploring the potential of [11C]choline-PET/CT as a novel imaging biomarker for predicting early treatment response in prostate cancer

  2014cites this paper
• Nuclear Medicine Imaging in Cancer

  2014cites this paper
• [Salvage treatments following prostate radiation therapy: role of the urologist].

  2014cites this paper
• Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study

  2014cites this paper
• Salvage therapy of small volume prostate cancer nodal failures: a review of the literature.

  2014cites this paper
• The role of positron emission tomography/computed tomography imaging with radiolabeled choline analogues in prostate cancer.

  2014cites this paper
• Traitements de rattrapage après irradiation prostatique : place de l’urologue

  2014cites this paper
• Pattern of occult nodal relapse diagnosed with (18)F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy.

  2014cites this paper
• Serum tumor markers and PET/CT imaging for tumor recurrence detection

  2013cites this paper
• [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].

  2013cites this paper
• Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics

  2013cites this paper
• When to perform positron emission tomography/computed tomography or radionuclide bone scan in patients with recently diagnosed prostate cancer

  2013cites this paper
• Translational Molecular Imaging of Prostate Cancer

  2013cites this paper
• PET Imaging of Inflammation Biomarkers

  2013cites this paper
• Can Choline PET Tackle the Challenge of Imaging Prostate Cancer?

  2012cites this paper